Solid Biosciences Inc. (SLDB) stock

SLDBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30

$6.84−0.16 (-2.29%)

Close on Nov 13, 2026Market cap $733.42MP/E –Yield –

Solid Biosciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Solid Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?